Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

Key facts

Sponsor

Children's Oncology Group

Principal Investigator

Anne L Angiolillo, MD

Children's Oncology Group

Intervention

Calaspargase Pegol-mknl(drug)

Enrollment

166 enrolled

Eligibility

2-30 years · All sexes

Timeline

2008 – 2021

Study locations (27)

• University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
• Children's Hospital of Orange County, Orange, California, United States
• Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States
• Children's Hospital Colorado, Aurora, Colorado, United States
• University of Connecticut, Farmington, Connecticut, United States
• Connecticut Children's Medical Center, Hartford, Connecticut, United States
• Children's National Medical Center, Washington D.C., District of Columbia, United States
• Lurie Children's Hospital-Chicago, Chicago, Illinois, United States
• Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States
• Riley Hospital for Children, Indianapolis, Indiana, United States
• Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States
• Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States
• Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota, United States
• University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States
• Washington University School of Medicine, St Louis, Missouri, United States
• +12 more locations on ClinicalTrials.gov

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT05621291
  A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...
  National Cancer Institute (NCI)
• ENROLLING BY INVITATIONNCT07511959
  Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative Dentistry
  Wroclaw Medical University
• RECRUITINGPHASE2NCT06738368
  Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
  University of Washington
• RECRUITINGNANCT07191119
  Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
  St. Jude Children's Research Hospital
• RECRUITINGNANCT07177183
  Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure
  University Hospital Ostrava
• RECRUITINGPHASE2NCT07275762
  Y-4 to Treat the Postherpetic Neuralgia
  Neurodawn Pharmaceutical Co., Ltd.
• RECRUITINGNANCT07201974
  Virtual Reality for Post-Stroke Gait Rehabilitation
  McGill University
• ENROLLING BY INVITATIONNCT07515430
  The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic Leukemia
  Sun Yat-sen University

See all trials for Acute lymphoblastic leukemia →